Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs


Carcinoembryonic Antigen, and it is Commonly Referred to by its Abbreviation ?CEA? in Medical and Scientific Contexts

Zhensin Min

Carcinoembryonic Antigen (CEA) is a glycoprotein that was originally discovered as a tumor marker in cancer research. It is a cell surface protein that is overexpressed in various cancers, particularly colorectal carcinoma, but can also be found at lower levels in healthy tissues. CEA has been extensively studied for its utility in cancer diagnosis, prognosis, and monitoring, as well as its potential as a therapeutic target. This abstract provides an overview of the structure, function, clinical significance, and current research related to CEA, highlighting its role in cancer management and its potential applications in the field of oncology.